Evidence for somatic selection of natural autoantibodies - PubMed (original) (raw)
Evidence for somatic selection of natural autoantibodies
T Martin et al. J Exp Med. 1992.
Abstract
Natural autoantibodies are primarily immunoglobulin M (IgM) antibodies that bind to a variety of self-antigens, including self-IgG. Accounting for a large proportion of the early B cell repertoire, such polyspecific autoantibodies are speculated to contribute to the homeostasis and/or competence of the primary humoral immune system. Recent studies indicate that the leukemia cells from most patients with chronic lymphocytic leukemia (CLL) also express such IgM autoantibodies. Similarly, the leukemia cells from many CLL patients react with murine monoclonal antibodies (mAbs) specific for crossreactive idiotypes (CRIs) associated with human IgM autoantibodies. In particular, leukemic cells frequently react with G6, a mAb specific for an Ig heavy chain (H chain)-associated CRI, and/or with 17.109, a mAb that defines a kappa light chain (L chain)-associated CRI. Generated against IgM rheumatoid factor (RF) paraproteins, G6 and 17.109 each recognize a major CRI that is present in many IgM RF paraproteins. Furthermore, over 90% of the IgM paraproteins found to bear both H and L chain-associated CRIs also are found to have RF activity. Molecular characterization of these CRIs demonstrates that each is a serologic marker for expression of a highly conserved Ig V gene. As such, the frequent production of IgM polyspecific autoantibodies in CLL simply may reflect the frequent use of such highly conserved autoantibody-encoding Ig V genes with little or no somatic mutation. To test this hypothesis, we generated murine transfectomas to pair the 17.109-reactive kappa L chain of SMI, a 17.109/G6-reactive CLL population, with the Ig H chain of SMI or other G6-reactive leukemia cells or tonsillar lymphocytes. Cotransfection of vectors encoding the Ig H and L chains of SMI generated transfectomas that produce IgM kappa RF autoantibodies reactive with human IgG1 and IgG4. In contrast to G6/17.109-reactive IgM kappa RF Waldenstrom's paraproteins, the SMI IgM kappa also reacts with several other self-antigens, including myoglobin, actin, and ssDNA. However, cotransfection of the SMI L chain with a vector encoding any one of 10 different G6-reactive Ig H chains generated transfectomas that produce IgM kappa antibodies without detectable polyspecific autoantibody activity. These results indicate that polyspecific antiself-reactivity of G6/17.019-reactive Ig is dependent on the somatically generated Ig third complementarity determining region. Collectively, these studies imply that selection may be responsible for the frequent expression of polyspecific autoantibodies in CLL and early B cell ontogeny.
Similar articles
- CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies.
Kipps TJ, Robbins BA, Tefferi A, Meisenholder G, Banks PM, Carson DA. Kipps TJ, et al. Am J Pathol. 1990 Apr;136(4):809-16. Am J Pathol. 1990. PMID: 1691593 Free PMC article. - Immunoglobulin V gene expression in CD5 B-cell malignancies.
Kipps TJ, Rassenti LZ, Duffy S, Johnson T, Kobayashi R, Carson DA. Kipps TJ, et al. Ann N Y Acad Sci. 1992 May 4;651:373-83. doi: 10.1111/j.1749-6632.1992.tb24638.x. Ann N Y Acad Sci. 1992. PMID: 1376056 Review. - Immunoglobulin V gene utilization in chronic lymphocytic leukemia and non-Hodgkin's B cell lymphomas.
Kipps TJ. Kipps TJ. Nouv Rev Fr Hematol (1978). 1988;30(5-6):293-8. Nouv Rev Fr Hematol (1978). 1988. PMID: 3065730 Review.
Cited by
- Anti-DNA IgA autoantibodies are spontaneously generated in mouse Peyer's patches.
Shimoda M, Inoue Y, Ametani A, Fujiwara J, Tsuji NM, Kurisaki J, Azuma N, Kanno C. Shimoda M, et al. Immunology. 1998 Oct;95(2):200-7. doi: 10.1046/j.1365-2567.1998.00582.x. Immunology. 1998. PMID: 9824476 Free PMC article. - Association of mesenchymal cells and immunoglobulins with differentiating epithelial cells.
Bukovsky A, Caudle MR, Keenan JA, Upadhyaya NB, Van Meter SE, Wimalasena J, Elder RF. Bukovsky A, et al. BMC Dev Biol. 2001;1:11. doi: 10.1186/1471-213x-1-11. Epub 2001 Jun 22. BMC Dev Biol. 2001. PMID: 11439174 Free PMC article. - Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
Rassenti LZ, Kipps TJ. Rassenti LZ, et al. J Exp Med. 1993 Apr 1;177(4):1039-46. doi: 10.1084/jem.177.4.1039. J Exp Med. 1993. PMID: 7681468 Free PMC article. - Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies.
Tarrago D, Aguilera I, Melero J, Wichmann I, Nuñez-Roldan A, Sanchez B. Tarrago D, et al. Immunology. 1999 Dec;98(4):652-62. doi: 10.1046/j.1365-2567.1999.00889.x. Immunology. 1999. PMID: 10594701 Free PMC article. - Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells.
Mariette X, Levy Y, Dubreuil ML, Intrator L, Danon F, Brouet JC. Mariette X, et al. Clin Exp Immunol. 1993 Nov;94(2):385-90. doi: 10.1111/j.1365-2249.1993.tb03461.x. Clin Exp Immunol. 1993. PMID: 8222331 Free PMC article.
References
- J Immunol. 1979 Oct;123(4):1548-50 - PubMed
- Mol Cell Biol. 1982 Sep;2(9):1033-43 - PubMed
- J Exp Med. 1990 Jan 1;171(1):189-96 - PubMed
- Am J Pathol. 1990 Apr;136(4):809-16 - PubMed
- J Clin Invest. 1991 Jun;87(6):2087-96 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous